K. Sze
发表
I. Ng,
C. Tang,
K. Chok,
2020,
Hepatology.
G. K. Chu,
I. Ng,
K. Sze,
2013,
Hepatology.
I. Ng,
D. Jin,
Y. Ching,
2004,
Journal of Biomedical Science.
G. K. Chu,
I. Ng,
K. Sze,
2014,
The Journal of pathology.
I. Ng,
D. Jin,
Y. Ching,
2008,
Cancer research.
I. Ng,
T. Cheung,
K. Sze,
2021,
Hepatology.
P. Sham,
S. Tsui,
I. Ng,
2019,
Cancer letters.
I. Ng,
T. Lee,
K. Sze,
2017,
Oncotarget.
P. Sham,
I. Ng,
C. C. Wong,
2021,
Nature Communications.
I. Ng,
K. Sze,
G. Chu,
2015,
Hong Kong medical journal = Xianggang yi xue za zhi.
I. Ng,
K. Sze,
L. Chan,
2011,
PloS one.
I. Ng,
K. Sze,
L. Chan,
2011
.
RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma
I. Ng,
C. C. Wong,
T. Lee,
2016,
Oncotarget.
I. Ng,
C. C. Wong,
Lai Wei,
2016,
Hepatology.
G. K. Chu,
Irene Oi-Lin Ng,
K. Sze,
2011,
Hepatology.
I. Ng,
Y. Ching,
K. Sze,
2010,
Liver international : official journal of the International Association for the Study of the Liver.
I. Ng,
C. C. Wong,
F. H. Tsang,
2018,
Oncogenesis.
I. Ng,
Wei Ma,
K. Sze,
2019,
Molecular carcinogenesis.
P. Sham,
S. Cherny,
I. Ng,
2016,
Journal of hepatology.
I. Ng,
C. C. Wong,
K. Sze,
2021,
Cell & Bioscience.
I. Ng,
T. Cheung,
Eva K. Lee,
2023,
Gut.
I. Ng,
C. C. Wong,
C. Chung,
2022,
Journal of hepatology.
I. Ng,
T. Lee,
K. Sze,
2017,
Oncotarget.
I. Ng,
K. Sze,
Y. Chiu,
2015,
Oncotarget.
I. Ng,
Eva K. Lee,
K. Sze,
2023,
Hepatology.
I. Ng,
Eva K. Lee,
K. Sze,
2023,
Hepatology.
C. Tang,
Eva K. Lee,
K. Sze,
2024,
Cellular and molecular gastroenterology and hepatology.